Bringing it closer to one of the world’s fastest-growing diagnostic market places, the Laboratory for Advanced Medicine (LAM)’s blood-based liver cancer test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). The test analyzes the DNA methylation pattern of cell-free DNA (cfDNA) non-invasively, and can indicate the presence of hepatocellular […]

FDA has granted breakthrough status to Laboratory for Advanced Medicine’s liver cancer liquid biopsy, the Irvine, California-based company said in a statement Tuesday. LAM secured the regulatory status after generating preliminary clinical data showing the test detects liver cancer with a specificity and sensitivity in excess of 95%. Like a rival test in development at Exact Sciences, […]

This interview is part of our new AI in Healthcare series, where we interview the world’s top thought leaders on the front lines of the intersections between AI and healthcare. In this interview, we speak with Dr. Krishnan Nandabalan, President and Chief Executive Officer at InveniAI, to understand how his company is using AI to transform healthcare, […]